Search research articles
Contact Us
Filters
Showing results (51-60 of 112) with videos related to
Page
of 12
Sort By:
Head & Neck
|
June 22, 2023
Implications of updated staging system for p16+ oropharyngeal squamous cell carcinoma: Is valuable prognostic information being omitted?
Kim Vo, Colton Ladbury, Andrew Tam, et al.
Therapeutic Advances in Medical Oncology
|
September 25, 2023
Role of immunotherapy in chondrosarcoma: A case report and review of the literature
Adam J Cohen-Nowak, Danielle B Dressler, Adam Rock, et al.
American Journal of Medical Genetics. Part A
|
April 17, 2026
Rate and Type of Surgery and Prevalence of Malignancy in Patients With Ollier's Disease and Maffucci Syndrome
Michael J Colello, Annika Y Myers, Jordan O Gasho, et al.
Head & Neck
|
March 29, 2014
Effect of induction chemotherapy on swallow physiology and saliva production in patients with head and neck cancer: a pilot study
Bharat B Mittal, Barbara Roa Pauloski, Alfred W Rademaker, et al.
Oncotarget
|
July 3, 2018
Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review
Young Kwang Chae, Lauren Chiec, Scott K Adney, et al.
Cancer Medicine
|
April 25, 2019
A phase II clinical study of 13-deoxy, 5-iminodoxorubicin (GPX-150) with metastatic and unresectable soft tissue sarcoma
Brian A Van Tine, Mark Agulnik, Richard D Olson, et al.
Oncotarget
|
November 17, 2016
Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials
Ricardo Costa, Benedito A Carneiro, Mark Agulnik, et al.
Cancer
|
August 9, 2022
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma
Julio Alvarenga Thiebaud, Vinod Ravi, Samuel Litwin, et al.
The Oncologist
|
August 5, 2010
A phase II study of pazopanib in patients with recurrent or metastatic invasive breast carcinoma: a trial of the Princess Margaret Hospital phase II consortium
Sara K Taylor, Stephen Chia, Susan Dent, et al.
Rare Tumors
|
January 10, 2025
Durable disease regression with copanlisib treatment in PI3K-mutated metastasizing ameloblastoma: A case report
Meghan M Lynch, Pedro Hermida-Viveiros, Sean Stencel, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 112) with videos related to
Sort By:
Page
of 12
Head & Neck
|
June 22, 2023
Implications of updated staging system for p16+ oropharyngeal squamous cell carcinoma: Is valuable prognostic information being omitted?
Kim Vo, Colton Ladbury, Andrew Tam, et al.
Therapeutic Advances in Medical Oncology
|
September 25, 2023
Role of immunotherapy in chondrosarcoma: A case report and review of the literature
Adam J Cohen-Nowak, Danielle B Dressler, Adam Rock, et al.
American Journal of Medical Genetics. Part A
|
April 17, 2026
Rate and Type of Surgery and Prevalence of Malignancy in Patients With Ollier's Disease and Maffucci Syndrome
Michael J Colello, Annika Y Myers, Jordan O Gasho, et al.
Head & Neck
|
March 29, 2014
Effect of induction chemotherapy on swallow physiology and saliva production in patients with head and neck cancer: a pilot study
Bharat B Mittal, Barbara Roa Pauloski, Alfred W Rademaker, et al.
Oncotarget
|
July 3, 2018
Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review
Young Kwang Chae, Lauren Chiec, Scott K Adney, et al.
Cancer Medicine
|
April 25, 2019
A phase II clinical study of 13-deoxy, 5-iminodoxorubicin (GPX-150) with metastatic and unresectable soft tissue sarcoma
Brian A Van Tine, Mark Agulnik, Richard D Olson, et al.
Oncotarget
|
November 17, 2016
Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials
Ricardo Costa, Benedito A Carneiro, Mark Agulnik, et al.
Cancer
|
August 9, 2022
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma
Julio Alvarenga Thiebaud, Vinod Ravi, Samuel Litwin, et al.
The Oncologist
|
August 5, 2010
A phase II study of pazopanib in patients with recurrent or metastatic invasive breast carcinoma: a trial of the Princess Margaret Hospital phase II consortium
Sara K Taylor, Stephen Chia, Susan Dent, et al.
Rare Tumors
|
January 10, 2025
Durable disease regression with copanlisib treatment in PI3K-mutated metastasizing ameloblastoma: A case report
Meghan M Lynch, Pedro Hermida-Viveiros, Sean Stencel, et al.
Page
of 12